YONGHE MED.GR.DL-0000025 (L97) — Capital Reinvestment Ratio
Latest as of December 2025:
0.04x
YONGHE MED.GR.DL-0000025 (L97) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (€495.53 Million) in capital expenditures (€18.90 Million). See L97 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
€495.53 Million
EUR
Capital Expenditures
€18.90 Million
EUR
Data as of
Dec 2025
Most recent filing
YONGHE MED.GR.DL-0000025 Capital Reinvestment Ratio (2021–2025)
This chart tracks YONGHE MED.GR.DL-0000025's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for YONGHE MED.GR.DL-0000025 (2021–2025)
Year-by-year Capital Reinvestment Ratio for YONGHE MED.GR.DL-0000025 from 2021 to 2025. For live market cap and broader valuation context, see how much is YONGHE MED.GR.DL-0000025 worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | €495.53 Million | €18.90 Million | ▼ -83.8% |
| 2024 | 0.24x | €228.62 Million | €53.76 Million | ▼ -46.1% |
| 2021 | 0.44x | €437.28 Million | €190.64 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow